STipe Therapeutics

STipe Therapeutics is a private biotechnology company with a vision to become a leader in the immune-oncology field, by developing novel drugs that target the STING (Stimulator of Interferon Genes) Pathway. The company focuses on harnessing the innate immune system to battle cancer and has developed first-in-class drugs targeting intracellular protein-protein interactions.